Related Experiment Videos

Short-term benefit from oral vancomycin treatment of regressive-onset autism

R H Sandler1, S M Finegold, E R Bolte

  • 1Section of Pediatric Gastroenterology and Nutrition, Rush Children's Hospital, Rush Medical College, Chicago, IL 60612, USA. rushstudy@aol.com

Insights

Antibiotic use may trigger regressive autism in some children by disrupting gut bacteria. A short-term trial showed improvement, suggesting a gut-brain link warrants further study.

Area of Science:

  • Neuroscience
  • Microbiology
  • Pediatrics

Background:

  • Autism spectrum disorder (ASD) typically emerges in early infancy.
  • A subset of children experiences regressive-onset autism, characterized by developmental regression after a period of normal development.
  • Parental reports link regressive autism to prior antibiotic exposure and chronic diarrhea.

Observation:

  • This study investigated the hypothesis that gut flora disruption by antibiotics could lead to neurotoxin-producing bacterial colonization in regressive autism.
  • Eleven children with regressive-onset autism, defined by specific criteria including antibiotic exposure, diarrhea, skill loss, and autistic features, were enrolled.
  • An intervention trial utilized a minimally absorbed oral antibiotic to assess its impact on gut flora and autistic symptoms.

Findings:

  • Short-term improvements in autistic symptomatology were observed in 8 out of 10 children, based on blinded videotape evaluations.
  • These positive outcomes were largely diminished at follow-up, indicating the antibiotic protocol was not a sustainable therapy.
  • The study highlights a potential correlation between gut microbiome alterations and autistic features in a specific subgroup.

Implications:

  • The findings suggest a possible gut-brain connection in the pathophysiology of regressive autism.
  • Further research into the gut microbiome's role may offer novel insights into autism's underlying mechanisms.
  • This could pave the way for future preventative or therapeutic strategies targeting the gut flora in certain children with autism.

Related Concept Videos